Literature DB >> 7404495

Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury.

R T Wall, J M Harlan, L A Harker, G E Striker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7404495     DOI: 10.1016/0049-3848(80)90175-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  61 in total

1.  Nutritional hyperhomocysteinaemia.

Authors:  I V Mohan; G Stansby
Journal:  BMJ       Date:  1999-06-12

Review 2.  Blood levels of homocysteine and atherosclerotic vascular disease.

Authors:  W G Christen; P M Ridker
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 3.  Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.

Authors:  Brahmajee K Nallamothu; A Mark Fendrick; Gilbert S Omenn
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 4.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

5.  MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate.

Authors:  Chao-Qiang Lai; Laurence D Parnell; Aron M Troen; Jian Shen; Heather Caouette; Daruneewan Warodomwichit; Yu-Chi Lee; Jimmy W Crott; Wei Qiao Qiu; Irwin H Rosenberg; Katherine L Tucker; José M Ordovás
Journal:  Am J Clin Nutr       Date:  2010-03-24       Impact factor: 7.045

6.  Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.

Authors:  M Watanabe; J Osada; Y Aratani; K Kluckman; R Reddick; M R Malinow; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

8.  Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

Authors:  Aurelio Jara-Prado; Alberto Ortega-Vazquez; Leticia Martinez-Ruano; Camilo Rios; Abel Santamaria
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

10.  The effect of ethchlorvynol on cultured endothelial cells. A model for the study of the mechanism of increased vascular permeability.

Authors:  R Wysolmerski; D Lagunoff
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.